vitamin K antagonists (VKAs)
Sponsors
Bayer, China National Center for Cardiovascular Diseases
Conditions
Atrial FibrillationVentricular Thrombus
Unknown Phase
Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events
CompletedNCT03462446
Start: 2015-06-01End: 2016-05-01Updated: 2018-03-12
Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
NCT05006677
Start: 2021-08-04End: 2023-12-30Target: 480Updated: 2023-03-02